Clinical trial
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
NCT00178841 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00178841 |
|---|---|
| Title | Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL |
| Official title | Open Label Pilot Study of Combination Therapy With Rosiglitazone and Bexarotene to Investigate a Possible Synergism in the Treatment of Cutaneous T-Cell Lymphoma |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cutaneous T-cell Lymphoma, Mycosis Fungoides, Sezary Syndrome |
| Intervention type | Drug |
| Interventions | Rosiglitazone and Bexarotene |
| Enrollment | 4 |
| Start date | Jun 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 17, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: